Effect of Hypocalcemia on the Outcome of Elderly Major Trauma Patients With Trauma-induced Coagulopathy
1 other identifier
observational
371
1 country
1
Brief Summary
Hypocalcaemia is an independent risk factor of TIC in elderly trauma patients. TIC combined with hypocalcemia had worse coagulation function and more serious acidosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
August 30, 2022
CompletedFirst Posted
Study publicly available on registry
September 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedSeptember 7, 2022
August 1, 2022
8.7 years
August 30, 2022
September 6, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Internationalized Normalized Ratio (INR)
coagulation function :Internationalized Normalized Ratio (INR)
24 hour
Activated Partial Thromboplastin Time (APTT)
coagulation function : Activated Partial Thromboplastin Time (APTT)
24 hour
Prothrombin Time (PT)
coagulation function : Prothrombin Time (PT)
24 hour
Secondary Outcomes (1)
Blood products rate
through study completion, an average of 1 week
Study Arms (2)
trauma induced coagulopathy
patients with INR\>1.2
non-trauma induced coagulopathy
patients with INR≤1.2
Interventions
Eligibility Criteria
Elderly patients with trauma were registered when they were admitted into intensive care unit affiliated to department of Emergency medicine (EICU) since January 2015 and September 2020
You may qualify if:
- age≥65 years old
- history of trauma
You may not qualify if:
- previous anticoagulants or antiplatelet medication;
- Coagulopathy caused by previous underlying diseases;
- Blood products transfused before admission;
- Cardiac arrest on admission;
- Malignant tumor;
- Data incomplete
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
SAHZU
Hanzhou, Zhejiang, 310009, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
yongan xu, doctor
Department of Emergency medicine,Second Affiliated Hospitalof Zhejiang University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 30, 2022
First Posted
September 7, 2022
Study Start
January 1, 2015
Primary Completion
September 1, 2023
Study Completion
September 1, 2023
Last Updated
September 7, 2022
Record last verified: 2022-08